Effects of busulfan, fludarabine and clofarabine treatment on human small intestinal organoids.
Instestinal organoids treated with either busulfan, fludarabine or clofarabine for 24h
- 12 samples
- DAC: EGAC00001000432
- Technology: NextSeq 500
- DS DUO:0000007 (version: 2021-02-23)disease specific researchThis data use permission indicates that use is allowed provided it is related to the specified disease.ModifiersMONDO:0004335
- NPUNCU DUO:0000018 (version: 2021-02-23)not for profit, non commercial use onlyThis data use modifier indicates that use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.
- PUB DUO:0000019 (version: 2021-02-23)publication requiredThis data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.
- COL DUO:0000020 (version: 2021-02-23)collaboration requiredThis data use modifier indicates that the requestor must agree to collaboration with the primary study investigator(s).
Access policy for study 'RNAseq busulfan-, fludarabine-, clofarabine-treated instestinal organoids'
For access please study the associated DUO terms for a dataset and/or contact dacdbg@umcutrecht.nl
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Other |